Decreased serum amyloid β1-42 autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid β1-42 peptide

Sylvia Brettschneider, Nils G. Morgenthaler, Stefan J. Teipel, Christina Fischer-Schulz, Katharina Bürger, Richard Dodel, Yansheng Du, Hans Jürgen Möller, Andreas Bergmann, Harald Hampel

Research output: Contribution to journalArticle

47 Scopus citations

Fingerprint Dive into the research topics of 'Decreased serum amyloid β<sub>1-42</sub> autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid β<sub>1-42</sub> peptide'. Together they form a unique fingerprint.

Medicine & Life Sciences